CPhI North America, an event designed to bring the complete North American pharma supply chain together, announced that Nik Leist, senior director of ingestible sensor manufacturing and site leader at Proteus Digital Health, will deliver the keynote address on day two of the 2nd Annual CPhI North America Conference.
Currently, Leist leads the teams responsible for the end-to-end manufacturing operations for Proteus’ novel ingestible sensor technology. His keynote session, “Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines,” will take place on Wednesday, April 25, from 1:15 pm to 2:00 pm. The session is open to all Conference Pass, Exhibitors, Expo Only, and VIP attendees.
During his keynote session, Leist will explore how the convergence of digital technologies and healthcare is fundamentally changing the way patients interact with their own health. With greater access to mobile applications and wearable devices, they are actively engaging with their medications in ways never seen before. Digital Medicines, developed over the last 16 years, and in real-world use in the last 2.5 years, is a driver of this change.
Leist will outline the steps required, including customizing machinery and partnering with global pharmaceutical companies to develop DigiMeds, a new category of pharmaceuticals that pairs medications with sensors to open the door for more informed decisions and conversations across the healthcare field while enabling integration of technology directly into medications.
“We are at a very exciting point in the evolution of digital medicines, now pushing the boundaries of digital health to facilitate individualized care, providing highly accurate diagnoses, and answering two of the most basic questions in healthcare: Did the patient take their medication, and did the medication work?,” Leist commented. “The fact that people are starting to embrace technology to improve their health outcomes will help shift the focus onto the prevention of diseases and adverse health conditions rather than solely on curing them.”
The CPhI North America conference agenda includes discussions on pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs, biopharmaceuticals, and biosimilars/biogenerics.
CPhI North America will take place April 24-26, 2018 at the Pennsylvania Convention Center in Philadelphia. More information is available at CPhINorthAmerica.com.
Filed Under: Drug Discovery